CLINICAL_TRIALS trial_result · 2023-11-18

Clinical Trial Update: Evaluation of Safety and Efficacy of RZL-012 in Subjects Seeking Fat Reduction in the Flanks [Phase 2]

Phase 2 clinical trial evaluating safety and efficacy of RZL-012 for fat reduction in the flank area has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Raziel Therapeutics Ltd. | Conditions: Flank Mass | Phase 2 | Status: COMPLETED | Results posted: 2023-11-18